Last reviewed · How we verify
Theophylline with azithromycin
Theophylline with azithromycin is a Small molecule drug developed by Zhujiang Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Theophylline with azithromycin |
|---|---|
| Sponsor | Zhujiang Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Theophylline with azithromycin CI brief — competitive landscape report
- Theophylline with azithromycin updates RSS · CI watch RSS
- Zhujiang Hospital portfolio CI
Frequently asked questions about Theophylline with azithromycin
What is Theophylline with azithromycin?
Theophylline with azithromycin is a Small molecule drug developed by Zhujiang Hospital.
Who makes Theophylline with azithromycin?
Theophylline with azithromycin is developed by Zhujiang Hospital (see full Zhujiang Hospital pipeline at /company/zhujiang-hospital).
What development phase is Theophylline with azithromycin in?
Theophylline with azithromycin is in Phase 1.
Related
- Manufacturer: Zhujiang Hospital — full pipeline
- Compare: Theophylline with azithromycin vs similar drugs
- Pricing: Theophylline with azithromycin cost, discount & access